share_log

Truist Securities Downgrades Treace Medical Concepts to Hold, Lowers Price Target to $7

Truist Securities Downgrades Treace Medical Concepts to Hold, Lowers Price Target to $7

信託證券將Treace Medical Concepts的評級下調至持有,將目標股價下調至7美元
Benzinga ·  05/08 08:47

Truist Securities analyst Richard Newitter downgrades Treace Medical Concepts (NASDAQ:TMCI) from Buy to Hold and lowers the price target from $17 to $7.

Truist Securities分析師理查德·內維特將Treace Medical Concepts(納斯達克股票代碼:TMCI)的評級從買入下調至持有,並將目標股價從17美元下調至7美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論